Kangmei Pharma | 600518 - 资产

金融业

CNY

CNY 13.31B

现金及等价物

CNY 1.23B

CNY 841.45M

CNY 6.8B

CNY 5.38B

CNY 173.71M

CNY -12.72M

CNY -12.72M

6.37K

EPS每股收益

CNY 0

股本和储备

CNY 7.31B

CNY 238.34M

债务利息支出

CNY 1.82M

CNY 2.44M

CNY 68.57M

CNY 19.55B

CNY -16.56M

CNY 1.09B

CNY -10.94M

普通股股本

CNY 13.83B

1.11K

CNY -14.01M

CNY 1.08B

销售和管理费用

CNY 237.06M

CNY 2.38B

贸易债权人

CNY 2.46B

应收帐款人

CNY 2.92B

	资产	更改		日
Akebia Therapeutics	USD 362.52M		14.04M	2026-03
Alaunos Therapeutics	USD 1.88M		1.08M	2026-03
Avita Medical	AUD 56.39M		1.74M	2025-12
Cspc Pharmaceutical	CNY 46.7B		695.56M	2025-12
Dianthus Therapeutics	USD 1.25B		715.96M	2026-03
Genomma Lab Internacional	MXN 24.8B		965.89M	2026-03
Hypermarcas	BRL 25.16B		4.34M	2025-12
Ionis Pharmaceuticals	USD 3.45B		74M	2026-03
IQVIA Holdings	USD 29.68B		269M	2026-03
Jiangsu Hengrui	CNY 71.29B		1.43B	2026-03
Kangmei Pharma	CNY 13.31B		375.64M	2026-03
Moderna	USD 11.49B		850M	2026-03
Organon & Co	USD 13B		129M	2026-03
Revvity	USD 12B		171.82M	2026-03
Sh Fosun Pharma	CNY 122.97B		2.91B	2026-03
Tectonic Therapeutic	USD 246.58M		14.46M	2026-03
Viatris	USD 36.83B		358.5M	2026-03
Wuxi Apptec	CNY 107.41B		4.29B	2026-03
Xeris Pharmaceuticals	USD 392.01M		8.49M	2026-03
Zz Pientze Pharmaceu	CNY 18.38B		905.93M	2026-03